Anaphylaxis Market Size Forecasted To Achieve 4.81 Billion By 2029 With Steady Growth

We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Anaphylaxis Market Size and Projected Growth Rate?
The market size for anaphylaxis has experienced significant growth in the past few years. The market is expected to expand from $3.24 billion in 2024 to $3.51 billion in 2025, boasting a compound annual growth rate (CAGR) of 8.4%. The growth observed during the historic period is due to factors such as the surge in food allergies, increased recognition of anaphylaxis, improvement in healTH*Care infrastructure, enhanced diagnosis and treatment, as well as the growing access to epinephrine auto-injectors.

In the coming years, firm growth is anticipated in the anaphylaxis market, which is predicted to escalate to $4.81 billion by 2029, at a compound annual growth rate (CAGR) of 8.2%. Factors contributing to the growth during the forecasting period involves enhancing urbanization and lifestyle changes, surging anaphylaxis incidents, growing disposable income in developing markets, government subsidies for allergy research, and breakthroughs in emergency treatment delivery systems. Key trends during the outlook period comprise of increasing demand for auto-injectors, integration of digital health solutions in managing anaphylaxis, heightened emphasis on product affordability, increase in preventative therapies and vaccines, and an augmented use of biologics for treating allergies.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21096

What Are the Major Segments in the Anaphylaxis Market?
The anaphylaxis market covered in this report is segmented -

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Beta-antagonists, Other Drug Class
2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration
3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:
1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials
2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids
3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists
4) By Beta-antagonists: Selective Beta-blockers, Non-selective Beta-blockers
5) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

What Are The Driving Anaphylaxis Market Evolution?
The increased occurrence of food allergies is projected to boost the expansion of the anaphylaxis market. These allergies are immune responses to specific foods, leading to symptoms that vary from mild to severe, including dangerous anaphylactic reactions. The mounting recurrence of food allergies is attributed to factors like altered eating patterns, environmental impacts, as well as increased cognizance and diagnosis. Treatment for anaphylaxis is crucial as it provides a life-saving solution for individuals suffering from food allergies by swiftly curbing severe allergic responses, reducing symptoms like swelling, breathing difficulties, and drops in blood pressure, ensuring quick stabilisation while preventing potentially lethal results and providing patients with the necessary tools to act promptly in the event of future allergic events. As of September 2024, the World Health Organization (WHO), a UN agency based in Switzerland, reported around 220 million individuals worldwide had food allergies. A single food item can contain multiple allergens, and a person can be allergic to more than one kind of food. Furthermore, in May 2024, according to a report by the Food Standards Agency's (FSA), named Patterns and Prevalence of Adult Food Allergy (PAFA), suggested that over 30% of adults had experienced adverse reactions to food and approximately 6% of UK adult population, approximately 2.4 million people, had clinically confirmed food allergies. Thus, the heightened frequency of food allergies is fuelling the expansion of the anaphylaxis market.

Which Firms Dominate The Anaphylaxis Market Segments?
Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy's Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

What Are the Latest Developing Trends in the Anaphylaxis Market?
Principal firms in the anaphylaxis market are striving to create cutting-edge epinephrine nasal sprays that can provide faster and more efficient drug delivery in emergency situations. Epinephrine nasal sprays are medical tools designed to distribute epinephrine, also known as adrenaline, through the nostrils to treat severe allergic reactions, including anaphylaxis. A significant example of this came in August 2024, when ARS Pharmaceuticals, a US-based biotech company, received Food and Drug Administration approval for Neffy (an epinephrine nasal spray), making it the sole needle-free therapy for type I allergic reactions, such as anaphylaxis. This novel nasal spray presents a non-intrusive alternative to conventional epinephrine autoinjectors, thereby potentially providing a more accessible solution for emergency treatment. The goal of Neffy is to enhance patient adherence by removing the necessity for needles, while providing quick and lifesaving epinephrine during severe allergic episodes.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Is The Largest Region In The Anaphylaxis Market?
North America was the largest region in the anaphylaxis market in 2024. The regions covered in the anaphylaxis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Anaphylaxis Market?
2. What is the CAGR expected in the Anaphylaxis Market?
3. What Are the Key Innovations Transforming the Anaphylaxis Industry?
4. Which Region Is Leading the Anaphylaxis Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.